Pharma channel feed

Law­mak­ers call for US in­ves­ti­ga­tion of Chi­nese con­tract re­search gi­ants

Last year
Manufacturing

Mar­ket­ingRx roundup: Pfiz­er, Astel­las' Su­per Bowl spots; Lil­ly de­buts new Alzheimer’s ad

Last year
Marketing

Am­gen dou­bles down on ‘bad’ cho­les­terol aware­ness with new cam­paign, free test­ing

Last year
Marketing

Organon shelves con­tra­cep­tive with 'nat­u­ral' es­tro­gen

Last year
FDA+

Judge toss­es PhRMA's suit over drug price ne­go­ti­a­tions in a win for the Biden ad­min­is­tra­tion

Last year
Law

Stake­hold­ers brace for bumps in rare pe­di­atric dis­ease PRV reau­tho­riza­tion

Last year
FDA+

Neu­rol­o­gists val­ue speed and ef­fi­ca­cy over safe­ty for ALS pipeline drugs, study finds

Last year
Marketing

FTC re­view pe­ri­ods end for Ab­b­Vie-Im­muno­Gen $10.1B deal and $4B BMS-Rayze­Bio buy­out

Last year
Deals

Take­da wins long-await­ed US ap­proval for first oral drug for eosinophilic esophagi­tis

Last year
FDA+

FDA ad­dress­es ex­pand­ed use of da­ta mon­i­tor­ing com­mit­tees in draft guid­ance

Last year
FDA+

Gilead to snap up liv­er dis­ease biotech CymaBay for $4.3B

Last year
Deals

Pfiz­er joins Su­per Bowl ad line­up, toast­ing Katal­in Karikó and oth­er in­no­va­tors with 'Here’s to Sci­ence' spot

Last year
Marketing

No­vo Nordisk se­cures first two wins in le­gal bat­tle against com­pound­ing phar­ma­cies, well­ness cen­ters

Last year
Law

As­traZeneca en­cour­ages NHL fans to get 'body checked' for can­cer

Last year
Marketing

FDA fi­nal­izes rule on us­ing mas­ter files in bi­o­log­ics ap­pli­ca­tions

Last year
FDA+

CSL and uniQure un­veil three-year da­ta for one-time he­mo­phil­ia B gene ther­a­py that costs $3.5M

Last year
R&D
Cell/Gene Tx

Sen­ate grills phar­ma CEOs, who emerge from hear­ing on drug prices large­ly un­scathed

Last year

House pass­es ban on use of QALYs in fed­er­al health pro­grams

Last year
FDA+

Ogilvy Health taps long­time WPP ex­ec Re­na­ta Ma­ia as chief cre­ative of­fi­cer

Last year
People
Marketing

Wall Street: GLP-1 com­peti­tors’ pain is Eli Lil­ly’s gain

Last year

As­traZeneca CEO calls open­ing IRA drug price of­fer 'rel­a­tive­ly en­cour­ag­ing' in first char­ac­ter­i­za­tion of talks

Last year
FDA+

Up­dat­ed: ‘Ruth­less’ pipeline pri­or­i­ti­za­tion, obe­si­ty and Chi­na: Three take­aways from As­traZeneca’s Q4 

Last year
China

House com­mit­tee plans hear­ing on Chi­nese biotech com­pe­ti­tion as ten­sions mount

Last year
China

New hear­ing, same blame game: Phar­ma, PBMs trade ac­cu­sa­tions ahead of Sen­ate ses­sion

Last year
First page Previous page 71727374757677 Next page Last page
A service from the Financial Times